Document is current
Any future updates will be listed below
-
Authors
Kallenborn, Felix https://orcid.org/0000-0003-4516-6357
Chacon, Alejandro
Hundt, Christian
Sirelkhatim, Hassan https://orcid.org/0009-0005-0944-3005
Didi, Kieran
Cha, Sooyoung https://orcid.org/0000-0001-7211-4603
Dallago, Christian https://orcid.org/0000-0003-4650-6181
Mirdita, Milot https://orcid.org/0000-0001-8637-6719
Schmidt, Bertil https://orcid.org/0000-0003-2597-8331
Steinegger, Martin https://orcid.org/0000-0001-8781-9753
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00250470, 2020M3-A9G7-103933, 2021-M3A9-I4021220, 2021-R1C1-C102065, RS-2024-00396026)
Deutsche Forschungsgemeinschaft (439669440 TRR319 RMaP TP C01)
Samsung (Creative-Pioneering Researchers Program)
Novo Nordisk Fonden (NNF24SA0092560)
- License Information
-
More Information
Article History
Received: 19 January 2025
Accepted: 14 August 2025
First Online: 18 September 2025
Competing interests
: C.D., A.C., C.H., H.S. and K.D. are employed by NVIDIA. M.S. declares an outside interest in Stylus Medicine. The other authors declare no competing interests.
